CDK4 (9C3) Monoclonal Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-51314M |
| Product Name | CDK4 (9C3) Monoclonal Antibody |
| Applications |
WB
IHC-P
|
| Reactivity | Human, Mouse |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Mouse |
| Source | This CDK4 antibody is generated from a mouse immunized with a recombinant protein. |
| Clonality | Monoclonal |
| Clone # | 9C3 |
| Isotype | IgG2a |
| Concentration | 0.5ug/ul |
| Purification | Purified by Protein G. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C for 12 months. |
| Target | |
| Gene ID | 1019 |
| Swiss Prot | P11802 |
| Synonyms | CMM3; PSK-J3; Cyclin-dependent kinase 4; Cell division protein kinase 4; CDK4 |
| Background | Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. |
| Application Dilution | |
| WB | 1:300-5000 |
| IHC-P | 1:200-400 |